Compare First-Line Meds for Parkinson’s
About 60,000 people in the US are diagnosed with Parkinson’s disease each year...and you’ll need to help sort through first-line meds.
Meds don’t slow progression, so consider using a “wait-and-see” approach...starting when symptoms impair function or quality of life.
Tailor med choice based on age, symptom severity, etc.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote